CoChat

The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection

Open access

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.

Abstract

Transient transfection of foreign DNA is the most widely used laboratory technique to study gene function and product. However, the transfection efficiency depends on many parameters, including DNA quantity and quality, transfection methods and target cell lines. Here, we describe the considerable advantage of mRNA electroporation compared to conventional DNA-based systems. Indeed, our methodology offers extremely high transfection efficiency up to 98% regardless of the cell line tested. Protein expression takes place a few hours post-transfection and lasts over 72 h, but overall, the electrotransfer of mRNAs enables the monitoring of the level of protein expressed by simply modulating the amount of mRNAs used. As a result, we successfully conducted cell imaging by matching the levels of expressed VHHs and the antigen present in the cell, preventing the necessity to remove the excess unbound VHHs. Altogether, our results demonstrate that mRNA electrotransfer could easily supplant the conventional DNA-based transient expression system.

Overview

CoChat Summary

TL;DR

mRNA electrotransfer achieved extremely high transfection efficiency (up to ~99–100%) across multiple cell lines, with rapid and tunable protein expression, outperforming DNA electroporation and cationic polymer delivery in this study. The authors propose mRNA electroporation as a viable substitute for conventional DNA-based transient transfection.

Key findings

  • mRNA electroporation yielded approximately 100% transfection efficiency across all tested cell lines, whereas JetMESSENGER® efficiency was cell-line dependent (~80% in SiHa, 30–5% in Caski and MDA-MB231). DNA electroporation reached only 15% with 1 µg and 1.5% with 500 ng, with cell survival of ~30–50% versus ~85% for mRNA/JetMESSENGER®.
  • Protein expression from electrotransferred mRNA began as early as 6 h and lasted up to 72 h; expression level was controllable by mRNA amount (e.g., nano-GFP-NLS-mScarlet optimal at 100 ng; con1-NLS-mScarlet optimal at 50–25 ng; nano-Lamin-mScarlet optimal at 200 ng early and 50–200 ng at 24 h).
  • Functional validation included 16E6 mRNA reducing p53 in >99% of MDA-MB231 cells, TOX mRNA (100 ng) causing >95% cell death with an IC50 of 0.2 ± 0.03 ng, and co-electroporation of two mRNAs giving ~95% single/double transfection efficiency.

Methods

  • Compared mRNA delivery by electroporation (Neon™, 1200 V, 20 ms, 1 rectangular pulse) and JetMESSENGER® cationic polymer, plus DNA electroporation, in cell lines including MDA-MB231, HCC1954, MRC-5, Caski, SiHa, NK-92, AGS, HeLa-H2B2eGFP, MRC5-EYFP-pol η, and U-2OS.
  • mRNAs were synthesized by in vitro transcription from a T7 promoter, capped, poly(A)-tailed, and quality-controlled; readouts included direct/indirect immunofluorescence, flow cytometry, western blot, MTT cytotoxicity, and UV-C DNA damage.
  • Main analysis assessed transfection efficiency, cell viability, protein expression/localization, mRNA titration, and functional assays (p53 degradation, toxin killing, nanobody imaging, PCNA/pol η recruitment), with statistics by one-way ANOVA and Student’s t-test on at least three independent replicates.

Limitations

  • Stated in the paper: a major drawback is the requirement for meticulous operating procedures to prevent mRNA degradation during synthesis and handling.
  • Evident from the text: the study is limited to cultured cancer and immortalized cell lines; no primary cells or in vivo validation are reported.
  • Evident from the text: optimal mRNA amount depends on the target antigen and incubation duration, requiring titration for each application, and the DNA comparison was restricted to selected cell lines and conditions.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/cells12121591

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 mRNA transient transfection efficiency. (A) Direct fluorescent detection of mScarlet at 24 h post-transfection. MDA-MB213, Caski and SiHa cells were transfected with mRNA coding for the mScarlet using JetMESSENGER® or electroporation. Nuclei were stained with DAPI (blue). Scale bar, 20 μm. The percentage of transfection efficacy was quantified with ImageJ and blotted (n ≥ 60). (B) NK-92 cells were harvested 48 h post-transfection and analyzed with flow cytometry.
Figure 1 mRNA transient transfection efficiency. (A) Direct fluorescent detection of mScarlet at 24 h post-transfection. MDA-MB213, Caski and SiHa cells were transfected with mRNA coding for the mScarlet using JetMESSENGER® or electroporation. Nuclei were stained with DAPI (blue). Scale bar, 20 μm. The percentage of transfection efficacy was quantified with ImageJ and blotted (n ≥ 60). (B) NK-92 cells were harvested 48 h post-transfection and analyzed with flow cytometry.CC BY · PubMed Central
Figure 2 mRNA transient transfection efficiency. (A) Cartoon representing the degradation pathway of p53 via 16E6. (B) 24 h post-transfection of the 16E6 oncogenic protein or the mScarlet mRNAs; degradation of p53 was monitored with immunofluorescence using an anti-p53 rabbit (7F5) Ab followed by a secondary anti-rabbit Alexa448. Scale bar, 40 µm. Immunofluorescence images were quantified using Prism software (n ≥ 200). (C) Detection of 16E6 and mScarlet with western blot using 4C6 and penta-His primary Ab, respectively.
Figure 2 mRNA transient transfection efficiency. (A) Cartoon representing the degradation pathway of p53 via 16E6. (B) 24 h post-transfection of the 16E6 oncogenic protein or the mScarlet mRNAs; degradation of p53 was monitored with immunofluorescence using an anti-p53 rabbit (7F5) Ab followed by a secondary anti-rabbit Alexa448. Scale bar, 40 µm. Immunofluorescence images were quantified using Prism software (n ≥ 200). (C) Detection of 16E6 and mScarlet with western blot using 4C6 and penta-His primary Ab, respectively.CC BY · PubMed Central
Figure 3 mRNA encoding for TOX delivered into cells. (A) 100 ng of mRNA coding for either ∆TOX or TOX was transfected in HeLa and HCC1954 cell lines. (B) Increasing amounts of mRNAs were transfected in HeLa cells. (A,B) Survival was measured 72 h post transfection using the MTT assay.
Figure 3 mRNA encoding for TOX delivered into cells. (A) 100 ng of mRNA coding for either ∆TOX or TOX was transfected in HeLa and HCC1954 cell lines. (B) Increasing amounts of mRNAs were transfected in HeLa cells. (A,B) Survival was measured 72 h post transfection using the MTT assay.CC BY · PubMed Central
Figure 4 Visualization of the H2B2-GFP with the nano-GFP-NLS-mScarlet (A) The amount of mRNAs coding for nano-GFP fused to NLS-mScarlet transfected in the MDA-MB231 cells was titrated as indicated. Cells were fixed after 24 h and analyzed with fluorescence microscopy. Scale bar, 50 µm. The quantification was performed using ImageJ, and the statistical analysis was performed using GraphPad Prism 5.0. The Student’s t-test was performed: * p < 0.05, *** p < 0.001. (B) MDA-MB231 cells were transfected with 100 ng of mRNA encoding for the nano-GFP-NLS-mScarlet. After 24 h, cells were fixed and analyzed for the different phases of the cell cycle with direct fluorescence microscopy. Scale bar, 10 µm.
Figure 4 Visualization of the H2B2-GFP with the nano-GFP-NLS-mScarlet (A) The amount of mRNAs coding for nano-GFP fused to NLS-mScarlet transfected in the MDA-MB231 cells was titrated as indicated. Cells were fixed after 24 h and analyzed with fluorescence microscopy. Scale bar, 50 µm. The quantification was performed using ImageJ, and the statistical analysis was performed using GraphPad Prism 5.0. The Student’s t-test was performed: * p < 0.05, *** p < 0.001. (B) MDA-MB231 cells were transfected with 100 ng of mRNA encoding for the nano-GFP-NLS-mScarlet. After 24 h, cells were fixed and analyzed for the different phases of the cell cycle with direct fluorescence microscopy. Scale bar, 10 µm.CC BY · PubMed Central
Figure 5 PCNA and DNA pol η detection. (A) Titration of the mRNAs coding for con1-NLS and nano-GFP-NLS fused to mScarlet. Cells were fixed after 24 h and analyzed with fluorescence microscopy. Scale bar, 40 µm. The quantification was performed using ImageJ, and the statistical analysis was performed using GraphPad Prism 5.0. The Student’s t-test was performed *** p < 0.001. (B) Cells were transfected with either the mRNA encoding nano-GFP-NLS-mScarlet or with con1-NLS-mScarlet as indicated. After 24 h, cells were treated with UV-C and fixed 8 h post-treatment. Foci were visualized with direct fluorescence. Cartoons are representing the binding of both partners to PCNA IDCL domain. Scale bar, 10 µm.
Figure 5 PCNA and DNA pol η detection. (A) Titration of the mRNAs coding for con1-NLS and nano-GFP-NLS fused to mScarlet. Cells were fixed after 24 h and analyzed with fluorescence microscopy. Scale bar, 40 µm. The quantification was performed using ImageJ, and the statistical analysis was performed using GraphPad Prism 5.0. The Student’s t-test was performed *** p < 0.001. (B) Cells were transfected with either the mRNA encoding nano-GFP-NLS-mScarlet or with con1-NLS-mScarlet as indicated. After 24 h, cells were treated with UV-C and fixed 8 h post-treatment. Foci were visualized with direct fluorescence. Cartoons are representing the binding of both partners to PCNA IDCL domain. Scale bar, 10 µm.CC BY · PubMed Central
Figure 6 Cell cycle progression followed by nano-Lamin. MDA-MB231 cells were transfected with 50 ng of mRNAs coding for nano-Lamin-mScarlet. After 24 h, cells were fixed and analyzed with direct fluorescence microscopy. Scale bar, 10 µm.
Figure 6 Cell cycle progression followed by nano-Lamin. MDA-MB231 cells were transfected with 50 ng of mRNAs coding for nano-Lamin-mScarlet. After 24 h, cells were fixed and analyzed with direct fluorescence microscopy. Scale bar, 10 µm.CC BY · PubMed Central
Figure 7 Efficacy of single and double transfection of mRNAs. (A) Titration of the mRNA encoding for nano-Lamin-mScarlet after different incubation time points. MDA-MB231 cells were transfected with different amounts of mRNAs as indicated. Cells were fixed after 6, 12, 24, 48 and 72 h of incubation. Images were captured with fluorescence microscopy, and quantification was performed with ImageJ. Scale bar, 10 µm. (B) Double detection of lamin A and either eGFP-NLS or con1. MDA-MB231 cells were transfected with 50 ng of mRNA coding for nano-Lamin-mScarlet-E3 together with either 100 ng of mRNA coding for eGFP-NLS or 50 ng of con1-NLS-eGFP. After 24 h, the cells were fixed and analyzed with direct fluorescence microscopy. Scale bar, 10 µm. (C) Quantification with flow cytometry of single transfection of 100 ng of mRNA encoding for either nano-Lamin-mScarlet or con1-eGFP or together as indicated. The percentages of transfected positive cells are noted in each FACS plot.
Figure 7 Efficacy of single and double transfection of mRNAs. (A) Titration of the mRNA encoding for nano-Lamin-mScarlet after different incubation time points. MDA-MB231 cells were transfected with different amounts of mRNAs as indicated. Cells were fixed after 6, 12, 24, 48 and 72 h of incubation. Images were captured with fluorescence microscopy, and quantification was performed with ImageJ. Scale bar, 10 µm. (B) Double detection of lamin A and either eGFP-NLS or con1. MDA-MB231 cells were transfected with 50 ng of mRNA coding for nano-Lamin-mScarlet-E3 together with either 100 ng of mRNA coding for eGFP-NLS or 50 ng of con1-NLS-eGFP. After 24 h, the cells were fixed and analyzed with direct fluorescence microscopy. Scale bar, 10 µm. (C) Quantification with flow cytometry of single transfection of 100 ng of mRNA encoding for either nano-Lamin-mScarlet or con1-eGFP or together as indicated. The percentages of transfected positive cells are noted in each FACS plot.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 13 Not checked · 35 Own results and interpretations

19 more claims

Create a free account to see all 48 claims and to verify the 23 references still open.

See all claims — free account
  • It may state two separate claims as one. 21
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 32 references

Cited by

See all 6

Metadata

Authors
Juncker, T., Chatton, B., & Donzeau, M.
Affiliations
Biotechnologie et Signalisation Cellulaire (FR)
Corresponding author
Donzeau, Mariel
Venue
Cells
Publisher
MDPI AG
Published
2023-06-08
Volume
12
Issue
12
Pages
1591
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4380082544
Cited by
6
References
32
Citations by year
2026: 1 · 2024: 4 · 2023: 1
FWCI
0.64
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Centre National de la Recherche Scientifique (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
  • University of Strasbourg (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
  • French Ministry of Research (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
  • Ligue Régionale contre le Cancer (CCIR-GE) (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
  • Fondation ARC pour la recherche sur le cancer (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
  • ITI Innovec (IdEx) (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
  • SFRI (ANR-10-IDEX-0002, ANR-20-SFRI-0012)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Inactivation Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Molecular Biology Techniques and Applications
Keywords
mRNA electroporation, transient transfection, transfection efficiency, nanobodies, protein expression, cell imaging, antigen detection
MeSH terms
Cell Line, DNA, Transfection, Gene Transfer Techniques, Electroporation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection. https://app.cochat.ai/papers/10.3390/cells12121591
The paper
Juncker, T., Chatton, B., & Donzeau, M. (2023). The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection. Cells. https://doi.org/10.3390/cells12121591

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.